BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31191026)

  • 1. Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer.
    Chen Z; Dai W; Yang L; Yang H; Ding L; He Y; Song X; Cui J
    Cancer Manag Res; 2019; 11():4691-4697. PubMed ID: 31191026
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
    Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
    Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of CCBE1 expression in human colorectal cancer.
    Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
    Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of G protein-coupled receptor 31 as a poor prognosticator in human colorectal cancer.
    Rong YM; Huang XM; Fan DJ; Lin XT; Zhang F; Hu JC; Tan YX; Chen X; Zou YF; Lan P
    World J Gastroenterol; 2018 Nov; 24(41):4679-4690. PubMed ID: 30416315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of A Proliferation-Inducing Ligand expression with the clinical pathology and prognosis in colorectal carcinoma].
    Mei HJ; Wang H; Zheng XB; Jin Q; Wang Y; Huang F; Zhang S
    Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(40):3232-3235. PubMed ID: 27852390
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
    Huang L; Fang J; Wu J; Zhou X; Wei H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody.
    Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
    Surgery; 2002 May; 131(5):541-7. PubMed ID: 12019408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMEM16A overexpression indicates poor prognosis in colorectal cancer patients.
    Liu JJ; He F; Guo SB
    Rev Esp Enferm Dig; 2022 Jul; 114(7):390-394. PubMed ID: 34607443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of gankyrin protein expression in human colorectal cancer with postoperative prognosis].
    Wu Q; He F; Yang P; Wang C; Chen X; Wang Q; Liu F; Cao J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):611-5. PubMed ID: 26108780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients.
    Zhang JH; Li AY; Wei N
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2103-2107. PubMed ID: 28537675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
    Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
    [No Abstract]   [Full Text] [Related]  

  • 19. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery.
    Tokunaga Y; Hosogi H; Hoppou T; Nakagami M; Tokuka A; Ohsumi K
    Oncol Rep; 2001; 8(4):815-9. PubMed ID: 11410790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.